KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53 - Ezequiel J. Tolosa; Glancis L. Raja Arul; Ashley N. Sigafoos; Victoria Ferrero; David R. Pease; Luciana L. Almada; Renzo E. Vera; Nicole M. Pena Ruiz; Tara L. Hogenson; Kayla C. LaRue-Nolan; Brooke R. Tader; Rondell P. Graham; et al. (Journal of Biological Chemistry, 2026)